Establishment and functional characterization of human peritoneal fibroblasts in culture: Regulation of interleukin-6 production by proinflammatory cytokines

Journal of the American Society of Nephrology

Volumn 7, Issue 10, 1996, Pages 2192-2201

  Jörres, Achim ^a   Ludat, Klaus ^a   Lang, Janine ^b   Sander, Kai ^a   Gahl, Gerhard M ^a   Frei, Ulrich ^a   DeJonge, Koen ^a   Williams, John D ^b   Topley, Nicholas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cell culture; Cytokines; Human peritoneal fibroblasts; Interleukin 6; Peritoneal dialysis

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0030377556     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pollock CA, Ibels LS, Eckstein RP, et al.: Peritonea morphology on maintenance dialysis. Am J Nepnrol 1989;9:198-204.
2. Verger C, Brunschvicg O, Le Charpenuer Y, Lavergne A, Vantelon J: Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1981;18:199-205.
3. Dobbie JW: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12:14-27.
4. Di Paolo N, Sacchi G, De Mia M, et al.: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986;44:204-211.
5. Dobbie JW, Lloyd JK, Gall CA: Categorization of ultrastructural changes in peritoneal mesothehum, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 1990;6:3-12.
6. Dobbie JW: Morphology of the peritoneum in CAPD. Blood Purif 1989;7:74-85.
7. Rubin J, Herrera GA, Collins D: An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991;18:97-102.
8. Lanfrancone L, Boraschi D, Ghiara P, et al.: Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor (CSF), granulocyte-monocyte-CSF, macrophage-CSF, interleukm-1 (IL-1) and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992;80:2835-2842.
9. Jonjic N, Peri G, Bernasconi S, et al.: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992;176: 1165-1174.
10. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989;68:31-36.
11. Nakagawa H, Ikesue A, Hatakeyama S, et al: Production of an interleukin-8-like chemokine by cytokine-stimulated rat NRK-49F fibroblasts and its suppression by anti-inflammatory steroids. Biochem Pharmacol 1993;45:1425-1430.
12. Elias JA, Reynolds MM, Kotloff RM, Kern JA: Fibroblast interleukin 1 beta: Synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation. Proc Natl Acad Sci USA 1989; 86:6171-6175.
13. Schröder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E: IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990;144:2223-2232.
14. Mielke V, Bauman JG, Sticherling M, et al: Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study. J Immunol 1990; 144:153-161.
15. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR: Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993;268:5834-5839.
16. Rolfe MW, Kunkel SL, Standiford TJ, et al: Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am J Physiol 1992; 263:L536-L545.
17. Topley N, Brown Z, Jörres A, et al: Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 1993;142:1876-1886.
18. Topley N, Jörres A, Luttmann W, et al: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993;43: 226-233.
19. Topley N, Petersen MM, Mackenzie RK, et al: Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994;46:900-909.
20. Topley N, Mackenzie RK, Jörres A, Coles GA, Davies M, Williams JD: Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity. Perit Dial Int 1993;13[Suppl 2]:S282-S285.
21. Bornstein MD: Reconstituted rat tail collagen used as a substrate for tissue cultures and coverslips in Maximow slides and roller tubes. Lab Invest 1958;7:134-139.
22. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-1570.
23. Redinbaugh MG, Campbell WH: Adaptation of the dye-binding protein assay to micro titer plates. Anal Biochem 1985;147:144-147.
24. Zilberstein A, Ruggieri R, Korn JH, Revel M: Structure and expression of cDNA and genes for human interferon-beta-2 a distinct species inducible by growth-stimulatory cytokines. EMBO J 1986;5:2529-2537.
25. O'Bryan JP, Frye RA, Cogswell PC, et al: axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991;11:5016-5031.
26. Jörres A, Topley N, Steenweg L, Müller C, Köttgen E, Gahl GM: Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992;12:80-85.
27. May LT, Santhanam U, Sehgal PB: On the multimeric nature of natural human interleukin-6. J Biol Chem 1991;266:9950-9955.
28. Krieg T, Heckmann M: Regulatory mechanisms of fibroblast activity. Recent Prog Med 1989;80:594-598.
29. Selgas R, Lopez Rivas A, Miranda B, et al.: Characterisation of the mitogenic-induced capacity of peritoneal effluent on human and mice fibroblasts in culture. Nephrol Dial Transplant 1991;6:44-50.
30. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991;40:77-79.
31. Fieren MW, van den Bernd GJ, Bonta IL.: Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta. Prostaglandins Leukotrienes Essent Fatty Acids 1992;47:23-28.
32. Fieren MW, van den Bernd GJ, Bonta IL, Ben Efraim S.: Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. J Clin Lab Immunol 1991;34:1-9.
33. Goldman M, Vandenabeele P, Moulart J, et al.: Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990;56:277-280.
34. Brauner A, Hylander B, Wretlind B: Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993;22:430-435.
35. Zemel D, Krediet RT, Koomen GCM, Kortekaas WMR, Geertzen HGM, ten Berge RJM: Interleukin-8 during peritonitis in patients treated with CAPD: An in-vivo model of acute inflammation. Nephrol Dial Transplant 1994;9:169-174.